Genvor (QB)【GNVR】銘柄情報

Genvor Inc (QB) (GNVR) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.50

( -1.96% )

買値

0.10

売値

0.7919

出来高

100

0.50 日の範囲 0.50

0.000001 52 週間の範囲 3.00

時価総額

18.105M

前日終値

0.51

始値

0.50

時刻

100

0.5

最終取引時間

財務取引量

US$ 50

VWAP

0.50

平均取引量 (3 か月)

US$ 3,684

発行済株式数

36,210,120

配当利回り

PER

-11.41

1 株当たり利益 (EPS)

-0.04

歳入

純利益

-1.29M

Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include fo... Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization. Genvor Incorporated is based in Henderson, Nevada. 詳細を表示

セクター

業界

ウェブサイト

www.genvor.com

本社

Henderson, United States

設立

Genvor Inc (QB) is listed in the sector of the その他OTC with ticker GNVR. The last closing price for Genvor (QB) was US$0.51. Over the last year, Genvor (QB) shares have traded in a share price range of US$ 0.000001 to US$ 3.00.

Genvor (QB) currently has 36,210,120 shares in issue. The market capitalisation of Genvor (QB) is US$18.11 million. Genvor (QB) has a price to earnings ratio (PE ratio) of -11.41.

Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions

Woodland, CA, March 04, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR), a biotechnology company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.05	-9.09090909091	0.55	0.7	0.4	6857	0.51	CS
4	0.17	51.5151515152	0.33	0.7	0.1511	15598	0.42490566	CS
12	0.035	7.52688172043	0.465	0.85	0.1511	7388	0.47077857	CS
26	-1.2	-70.5882352941	1.7	1.8	0.014	4022	0.54422118	CS
52	0.499999	49999900	1.0E-6	3	1.0E-6	2760	0.66877808	CS
156	-3.5	-87.5	4	10.01	1.0E-6	2546	1.23650626	CS
260	-3.5	-87.5	4	10.01	1.0E-6	2546	1.23650626	CS